Eliminating Disease-Carrying Pests and Restoring Enjoyment of the Great Outdoors
- Executive Order Number
- 14433
- President
- Donald Trump
- Signed
- September 29, 2026
- Published
- October 2, 2026
- Source
- Federal Register
- Original Document
- https://www.govinfo.gov/content/pkg/FR-2026-10-02/pdf/2026-20320.pdf
AI-Generated Summary
Purpose This executive order establishes a federal policy to suppress tick and mosquito populations, particularly invasive species, through non-chemical and technology-enabled methods. It aims to reduce disease transmission, protect public health and quality of life, and support related goals in the District of Columbia.
Key Actions or Directives
- Directs the Secretaries of the Interior and Agriculture, the EPA Administrator, and the GSA Administrator, in consultation with HHS, to launch a D.C.-focused campaign within 60 days targeting a 90% reduction in invasive mosquitoes and 50% reduction in ticks by 2028.
- Requires remediation of breeding grounds on federal lands, control of host populations (e.g., rodents and deer), and priority use of sterile insect techniques and safe biotechnologies.
- Mandates EPA to develop a regulatory framework for advanced control technologies within 60 days and expedite registration of safe, effective products.
- Instructs HHS to issue prize competitions or direct R&D for diagnostics, prophylactics, and therapeutics for specified tick- and mosquito-borne diseases, including alpha-gal syndrome, within 90 days.
- Requires USDA to issue prize competitions or direct research for non-chemical disease reduction methods within 90 days.
- Directs USDA and HHS to explore alpha-galactose labeling for food and drug products.
- Requires agency review of resources for implementation, coordinated with OMB.
Significant Changes to Policy or Law The order creates no new statutory authorities or enforceable rights. It prioritizes non-chemical and biotechnological approaches over conventional pesticides, integrates efforts with prior executive orders on D.C. beautification and biological research safety, and establishes specific reduction targets and timelines for the first time in this domain.
Potential Impacts
- Government agencies: Requires coordinated action by Interior, Agriculture, EPA, GSA, and HHS, with possible resource reallocations.
- Citizens and local areas: Aims to lower incidence of listed diseases, reduce pest nuisance in D.C. and potentially nationwide, and improve outdoor access while minimizing effects on beneficial species.
- Industry and research: Encourages development and commercialization of sterile insect techniques, genetic tools, and related products through regulatory streamlining and prize competitions.
- International relations: Positions the U.S. to lead in safe population-control technologies.
Main Stakeholders Affected Federal agencies (Interior, Agriculture, EPA, GSA, HHS), the District of Columbia government, private industry and academic researchers in biotechnology and pest control, healthcare providers and patients affected by tick- and mosquito-borne illnesses, pet and livestock owners, and the general public.
Notable Legal, Constitutional, or Political Implications The order explicitly preserves existing legal authorities, remains subject to appropriations, and creates no private right of action. Implementation must align with applicable environmental and biosafety laws referenced in related executive orders.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.